Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 8 Prostatic Neoplasms 5 Polycystic Ovary Syndrome 5 Multiple Myeloma 5 Colorectal Neoplasms 5 Small Cell Lung Carcinoma 4 Rectal Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 3 Stomach Neoplasms 2 Pancreatic Neoplasms 2 Fibrosis 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Hepatocellular 2 Breast Carcinoma In Situ 2 Wilms Tumor 1 Waldenstrom Macroglobulinemia 1 Venous Thromboembolism 1 Urinary Bladder Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Thrombosis 1 Sprains and Strains 1 Smoldering Multiple Myeloma 1 Sepsis 1 Sarcoma, Ewing 1 Sarcoma, Clear Cell 1 Sarcoma 1

Interventions

telapristone acetate 18 ulipristal acetate 17 Uterine Myomectomy 13 vilaprisan 12 Leuprolide 11 relugolix 9 estradiol, norethindrone drug combination 9 asoprisnil 9 elagolix 7 Uterine Artery Embolization 7 Mifepristone 7 Estradiol 7 Bupivacaine 7 ulipristal 6 Tranexamic Acid 6 Saline Solution 5 Norethindrone Acetate 5 linzagolix 4 epigallocatechin gallate 4 Sodium Chloride 4 Letrozole 4 Hysterectomy 4 Vitamin B 6 3 Sugars 3 Misoprostol 3 Lidocaine 3 Gonadotropin-Releasing Hormone 3 Embolization, Therapeutic 3 cetrorelix 2 Vitamin D 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Leiomyoma × Simvastatin × Clear all

NCT03400826 2025-07-14

Effects of Simvastatin on Uterine Leiomyoma Size

Johns Hopkins University

Phase 2 Recruiting

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡